Dabur Q2 Review: Systematix Maintains ‘Hold’ On Unconvincing Outlook — What Indian Investors Should Know
Dabur Q2 Review: A Closer Look at the Numbers and What They Mean for Investors Dabur India Ltd.’s recent growth trends have been underwhelming, especially in Q2 FY26, which was off an exceptionally weak base quarter in healthcare and beverages. The twin impact of GST and seasonality has also had a significant effect on the […]